logo
I Spent $125 to Generate 5 AI Videos a Day With Google's Veo 3. The Sound Sets It Apart

I Spent $125 to Generate 5 AI Videos a Day With Google's Veo 3. The Sound Sets It Apart

CNET30-05-2025
I am just a girl who wants to be on a warm beach but most of the time, I'm trapped behind a computer screen. So, like any reporter who tests and reviews AI, I make my days more bearable by using these AI programs to create alternative-timeline versions of myself somewhere where Jimmy Buffett is playing and you can smell the salt. Here's what Google's newest AI video model, Veo 3, came up with.
My beach bonfire party dream-turned-prompt is usually my first test as I put a new AI generator through its paces. And I admit, I had pretty low expectations for Veo 3. While I did see some social media posts gawking at Veo 3's capabilities, I've seen enough slop and hallucinations to approach with skepticism. Google's AI creative products, in particular, have always felt like a bit of an afterthought to me, something the company adds on to its extensive Gemini offerings to compete with the other tech heavyweights. But this year at the company's annual I/O developer conference, Google's Imagen 4, Veo 3 and Flow all took center stage. So I dove into Veo 3.
Without spoiling anything, I walked away from Veo feeling like this was the next natural step for Google, with one feature in particular giving the company an edge that might make it a more serious contender in the AI creative space. But there are serious limits and annoyances that I hope are addressed soon. Here's how my experience went and what you need to know.
Veo 3 availability, pricing and privacy
Veo 3 is currently available for Gemini Ultra users in the US and enterprise Vertex users. In other words, you'll need to pay up to play around with the new Veo. Ultra is Gemini's newest, priciest tier at $250 per month. (It's currently half off for $125 per month for three months.) Vertex is Google's AI enterprise platform, and you'll know if you have access to it.
If you don't want to pay hundreds of dollars for access to Google's AI video tools -- and I don't blame you -- you can try out Veo 2 with Google AI's Pro plan. I found that the one-month free trial is enough time to figure out if you want to pay the $20 per month fee to continue using it. You can check out my hands-on testing with that model for more info.
Google's Gemini privacy policy says the company can collect your info to improve its technologies, which is why it recommends not sharing any confidential information with Gemini. You also agree to Google's prohibited use policy, which outlaws the creation of abusive or illegal content.
My wild ride with Veo 3
The most impressive thing about Veo 3 is its new audio generation capabilities. You don't have to tell Gemini in your prompt that you want sound; it will automatically add it. This is a first among competitors like OpenAI's Sora and Adobe's Firefly and it certainly gives Google a huge edge.
While the AI audio is a nice perk, it isn't perfect. If you're familiar with the somewhat clunky nature of AI-generated music and dialogue, you'll be able to identify it immediately. But there were times when it flowed more naturally. The clashing metal sounds and grunts in my alien fight scene were timed perfectly to their attacks, something that would've been difficult to add on my own afterward. But the dinosaur-like aliens also literally say "roar" and "hiss" instead of making those noises.
My kayaker's paddling very nearly matched up with the water sloshing sound. The nature ambience in that video was particularly lovely and added a layer of depth that's been missing from AI videos. My dream beach bonfire partiers didn't sound like any party I've ever been to, but still, points for being first and relatively unproblematic.
Of course, while the audio was nice, it doesn't take away from the weird eccentricities that continue to plague AI generators. I ran into a few hiccups, mostly with people's faces, a notoriously hard thing for AI to mimic. But compared to the glaringly obvious errors I ran into with Veo 2, the new generation does appear to have made real improvements as Google claimed it did.
I run into hallucinations a lot when I'm testing AI image and video generators, so the first thing I do is look for whether a service gives me the ability to edit it. Veo 3 doesn't offer any of these, which is a bummer. It's certainly something that's going to make it less useful for professional creators, who are used to more fine-tuning editing tools and need to make precise tweaks for their projects. You can send a follow-up prompt asking for specific changes. For example, I asked Veo to change the angle in the previous video so I could see her face, which the program handled well.
With Veo 3, you'll typically have to wait 3 to 5 minutes for a new, edited video to load, though. Veo 3 has the longest generation time of any AI video generator I've tested. But the addition of audio to the videos excuses the longer wait time in my eyes.
The worst part of Veo 3 is how quickly I hit my daily generation limit. After only five videos, I was barred for an entire 24-hour period -- something that really annoyed me and made it much harder to assess. Google's VP of Gemini and Google Labs, Josh Woodward, said in a post on X/Twitter that Ultra subscribers like me have the highest number of generations that reset daily, in the regular Gemini app and in Flow. And for me, that limit in Gemini was five videos. Flow's limit is 125, according to Woodward.
I reached out to Google to get clarity on what the daily limit is for Ultra users creating through Gemini that Woodward mentions. Here's the response: "Google AI Ultra subscribers get the highest level of access to Veo 3, our state-of-the-art video generation model, which they can use in both the Gemini app and Flow, our new AI filmmaking tool."
The limits are another sign that this isn't a tool meant for professional creation and iterative editing. You need to spend time thoughtfully crafting your prompt and if Google flubs a face or glitches, you're likely to run out of credits fast and end up out of luck. Veo 3 is better suited for AI enthusiasts who want to dip their toes in video creation, not creators experimenting with AI.
Is Veo 3 worth the cost?
After an underwhelming experience with Veo 2, I had reservations about what to expect in the usefulness and accuracy of Veo 3. But the new model was impressive, the audio especially, even though it's still missing some key features.
Let me be clear: There is no rational reason to spend hundreds of dollars on a Gemini Ultra plan only to use Veo 3. If you want to dabble for fun, you can do that with Veo 2 for hundreds less per month, and if you're a creative professional, Veo 3 still lacks crucial features like editing. The Ultra plan does offer other features, like YouTube Premium, 30 terabytes of space and access to the newest Gemini models. So if you want any of those things, then, yeah, pay up and go play around with Veo 3. But it's not worth it on its own.
Veo 3 isn't the revolutionary upgrade those social media posts might lead you to believe. It is the next generation, better than last month's Veo 2, and it shows real promise in Google's future AI video endeavors. But be prepared to pay up if you want to try it out.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why Casella Waste Systems Stock Flopped on Friday
Why Casella Waste Systems Stock Flopped on Friday

Yahoo

time24 minutes ago

  • Yahoo

Why Casella Waste Systems Stock Flopped on Friday

Key Points The company's bottom-line miss in its second quarter was striking. That was compounded by a guidance reduction for full-year profitability. 10 stocks we like better than Casella Waste Systems › Solid waste and recycling management company Casella Waste Systems (NASDAQ: CWST) was surely eager to start its weekend. On Friday, the company published quarterly results that were a dud with investors, who sent its share price down by more than 5%. That was more deeply in the red than the S&P 500 index's 1.6% dive. One big whiff Much of this was because of a fairly wide bottom-line miss in Casella's second quarter, the results of which were published after market close Thursday. In the quarter, Casella booked revenue of over $465 million. So far, so good, as this was more than 23% higher than in the same quarter of 2024. Further down the profit and loss statement, however, the company revealed that its generally accepted accounting principles (GAAP) net income fell to $5.2 million ($0.08 per share) from the year-ago profit of slightly over $7 million. That drop was discouraging enough, but it was exacerbated by the fact that analysts were expecting far better from the company. On average, they were modeling $0.33 per share for bottom-line profitability, although they underestimated revenue with a collective $454 million projection. Acquisitions played a role in Casella's top-line growth, as the company completed six buyouts across the first half of this year. Management also said higher landfill volumes were a catalyst. Notable guidance revisions Outside of the bottom-line miss, Casella's change in guidance was dismaying for investors. Although it raised its outlook for full-year 2025 revenue -- $1.82 billion to $1.84 billion from just under $1.78 billion to a bit over $1.8 billion -- it cut that for profitability. The company now believes its GAAP net income will land at $8 million to $18 million; the previous guidance called for $10 million to $25 million. Should you buy stock in Casella Waste Systems right now? Before you buy stock in Casella Waste Systems, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Casella Waste Systems wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Casella Waste Systems Stock Flopped on Friday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Why Novo Nordisk Stock Bumped Higher on Friday
Why Novo Nordisk Stock Bumped Higher on Friday

Yahoo

time26 minutes ago

  • Yahoo

Why Novo Nordisk Stock Bumped Higher on Friday

Key Points The Federal government might boost its support of weight-loss drugs soon. According to a media report, it's contemplating a five-year, experimental program that would subsidize their costs for qualifying patients. 10 stocks we like better than Novo Nordisk › Unexpected news of a potential support program from the federal government boosted the share prices of weight-loss drug developers on Friday. The poster boy for that still rather small group, Wegovy/Ozempic maker Novo Nordisk (NYSE: NVO), understandably saw a stock price lift that day. It rose by more than 2%, contrasting well with the 1.6% slide of the S&P 500 index. Federal help for obesity drugs? That news came from The Washington Post, which published an article stating that the Trump administration is planning an experimental program that would cover the costs of such medications. Citing documents from the Centers for Medicare and Medicaid Services (CMS) it had obtained, the newspaper said the plan would be implemented by state Medicaid administrations. It would also be utilized by Medicare Part D insurance plans. These entities would be allowed to cover weight-loss drugs for qualifying patients. At the moment, Medicare generally covers such treatments for patients who suffer from type 2 diabetes. Both Novo Nordisk's Wegovy and rival Eli Lilly's Zepbound are essentially versions of predecessor diabetes drugs. Some private insurance plans cover obesity medications. The Post wrote that the experimental program will last for five years. Massive potential impact Novo Nordisk hasn't yet commented on the article, but we can be sure the company is excited about the prospect. Combined, Medicare and Medicaid are immense programs. Even if only a few states are willing to cover weight-loss treatments through them, the company could experience a surge in sales. For the stock's investors, this is a potentially very impactful development well worth monitoring. Should you buy stock in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Why Novo Nordisk Stock Bumped Higher on Friday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Addus HomeCare (ADUS) Q2 Earnings: What To Expect
Addus HomeCare (ADUS) Q2 Earnings: What To Expect

Yahoo

time27 minutes ago

  • Yahoo

Addus HomeCare (ADUS) Q2 Earnings: What To Expect

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting results this Monday afternoon. Here's what you need to know. Addus HomeCare missed analysts' revenue expectations by 0.6% last quarter, reporting revenues of $337.7 million, up 20.3% year on year. It was a mixed quarter for the company, with a narrow beat of analysts' sales volume estimates. Is Addus HomeCare a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Addus HomeCare's revenue to grow 20.8% year on year to $346.5 million, improving from the 10.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.46 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Addus HomeCare has missed Wall Street's revenue estimates three times over the last two years. Looking at Addus HomeCare's peers in the senior health, home health & hospice segment, some have already reported their Q2 results, giving us a hint as to what we can expect. BrightSpring Health Services delivered year-on-year revenue growth of 15.3%, beating analysts' expectations by 5.2%, and Option Care Health reported revenues up 15.4%, topping estimates by 4.6%. Option Care Health traded down 2.7% following the results. Read our full analysis of BrightSpring Health Services's results here and Option Care Health's results here. The euphoria surrounding Trump's November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the senior health, home health & hospice stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. Addus HomeCare is down 5.3% during the same time and is heading into earnings with an average analyst price target of $136.45 (compared to the current share price of $104.74). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store